ERBB receptors and cancer: the complexity of targeted inhibitors - PubMed (original) (raw)

Review

doi: 10.1038/nrc1609.

Affiliations

• PMID: 15864276
• DOI: 10.1038/nrc1609

Review

ERBB receptors and cancer: the complexity of targeted inhibitors

Nancy E Hynes et al. Nat Rev Cancer. 2005 May.

Erratum in

• Nat Rev Cancer. 2005 Jul;5(7):580

Abstract

ERBB receptor tyrosine kinases have important roles in human cancer. In particular, the expression or activation of epidermal growth factor receptor and ERBB2 are altered in many epithelial tumours, and clinical studies indicate that they have important roles in tumour aetiology and progression. Accordingly, these receptors have been intensely studied to understand their importance in cancer biology and as therapeutic targets, and many ERBB inhibitors are now used in the clinic. We will discuss the significance of these receptors as clinical targets, in particular the molecular mechanisms underlying response.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal